Status:
COMPLETED
Computer-Based Treatment for Social Anxiety Disorder
Lead Sponsor:
New York State Psychiatric Institute
Conditions:
Social Anxiety Disorder
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The present study is an open trial that seeks to examine the feasibility, acceptability, mechanism, and efficacy of a recently developed computer-based therapy in individuals with social anxiety disor...
Detailed Description
This randomized clinical trial examines the feasibility, acceptability, mechanism, and relative efficacy of two "doses" (standard 4-week/8 session vs. extended 8-week/12-session) of a recently develop...
Eligibility Criteria
Inclusion
- Males and females between the ages of 18 and 60
- Current primary diagnosis of SAD
- Score of at least 50 on the Liebowitz Social Anxiety Scale (Self-rated version)
- Fluent in English and willing and able to give informed written consent and participate responsibly in the protocol
- Normal or corrected-to-normal vision
Exclusion
- Present or past psychotic episode, psychotic disorder, schizophrenia, schizoaffective disorder, or bipolar disorder
- Current severe depression
- Suicidal ideation or behavior
- Current diagnosis of posttraumatic stress disorder, obsessive-compulsive disorder, bipolar disorder, manic episode or tic disorder
- Current or past organic mental disorder, seizure disorder, epilepsy or brain injury
- Current unstable or untreated medical illness
- Severe alcohol use disorder, severe cannabis use disorder, and any severity of other substance use disorder (except nicotine use disorders allowed)
- Use of psychiatric medication in the past month other than a stable dose of selective serotonin reuptake inhibitors (SSRIs) for a least 3 months
- Any concurrent cognitive behavioral therapy; other psychotherapy that was initiated in the past 3 months
- Pregnancy, or plans to become pregnant during the period of the study - will be assessed by urine
- Contraindication to MRI scanning:
- Paramagnetic metallic implants or devices contraindicating magnetic resonance imaging or any other non-removable paramagnetic metal in the body (e.g. pacemaker, paramagnetic metallic prosthesis, surgical clips, shrapnel, necessity for constant medicinal patch, some tattoos)
- Being unable to tolerate the scanning procedures (i.e., severe obesity, claustrophobia)
Key Trial Info
Start Date :
January 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT03415022
Start Date
January 30 2018
End Date
March 31 2020
Last Update
April 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032